- Home
- CRF vs MDXG Comparison
CRF vs MDXG Comparison
Compare CRF & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRF | MDXG |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 1997 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CRF | MDXG |
|---|---|---|
| Price | $7.33 | $4.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 1.5M | 748.2K |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | ★ N/A | $14.08 |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $5.81 | $4.48 |
| 52 Week High | $8.25 | $8.20 |
Technical Indicators
Market Signals| Indicator | CRF | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 45.12 | 30.54 |
| Support Level | $6.76 | N/A |
| Resistance Level | $8.04 | $5.38 |
| Average True Range (ATR) | 0.17 | 0.19 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 70.24 | 21.10 |
Price Performance
Historical ComparisonAbout CRF Cornerstone Total Return Fund Inc. (The)
Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology; Health Care; Financials; Communication Services; Consumer Discretionary; Industrials; Exchange-Traded Funds; Utilities; Energy; Real Estate and others.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.